A preliminary trial of low dose itraconazole therapy for Schizophyllum-sensitized asthma

A preliminary trial of low dose itraconazole therapy for Schizophyllum-sensitized asthma - low dose itraconazole therapy for Schizophyllum-sensitized asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007532

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophyllum-sensitized asthma

Interventions

Itraconazole 50mg/day for 14days PLS 20mg for 14days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: asthma patients who is sensitized with Schozophyllum commune

Exclusion criteria

Exclusion criteria: 1) Patients having abnormal shadow on chest X-ray 2) Patients having wheezing audible 3) Patients having obstructive disorders in pulmonary function testing 4) Patients having severe complications 5) Patients having pulmonary tuberclosis 6) Jpatients without agreement 7) Patients being pregnant, possible pregnant or breast-feeding a baby 8) Patients judged inappropriate by attending physisians

Design outcomes

Primary

Measure	Time frame
Efficasy of ITCZ on lung function	—

Secondary

Measure	Time frame
Efficasy of ITCZ on VAS or ACT	—

Countries

Japan

Contacts

Public ContactHaruhiko Ogawa

Ishikawa-ken Saiseikai Kanazawa Hospital. The Division of Pulmonary Medicine,

076-266-1060

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026